MLEC logo

Moolec Science SA (MLEC) Company Overview

Profile

Full Name:

Moolec Science SA

Sector:

Healthcare

Industry:

Biotechnology

Country:

Luxembourg

IPO:

March 2, 2021

Indexes:

Not included

Website:

http://moolecscience.com

Description:

Moolec Science SA (MLEC) focuses on developing plant-based proteins through innovative biotechnology. The company aims to create sustainable food solutions by using molecular farming to produce high-quality ingredients, making it easier for people to enjoy healthier and more environmentally friendly food options.

Key Details

Price

$0.76

Market Cap

$28.97 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$5.63 M(+521.56% YoY)

Annual EPS

-$0.19(+87.33% YoY)

PE Ratio

-

Annual ROE

-86.42%

Annual Debt To Equity

2.09

Beta

0.13

Events Calendar

Earnings

Next earnings date:

Mar 3, 2025

Recent quarterly earnings:

Oct 2, 2024

Recent annual earnings:

Oct 2, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 24 Maxim Group
Buy

Screeners with MLEC included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
Stocks below SMA 200
Most recommended stocks
Earnings today
Stocks below analysts price target
Healthcare sector
All stocks
Earnings this week
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.76
MLEC price is $0.76

Price All-time High

$19.25
MLEC price is currently -96.08% below its historical high of $19.25

Price Analysts Target

$3.00
MLEC price is currently -74.82% lower than the consensus analysts' forecast

Price Today Change

+2.11%
MLEC price is up +2.11% today

Price YTD Change

-6.44%
MLEC price is down -6.44% since January 1st

Price 3-Year Change

-92.37%
MLEC price is down -92.37% over the past 3 years

Market cap

Market Cap

$28.97 M
MLEC market capitalization is $28.97 million

Market Cap 3-Year Change

-
MLEC market capitalization 3-year change is unknown

Market Cap All-time High

$723.03 M
MLEC market capitalization is currently -95.99% below its historical high of $723.03 million

Market Cap Sector Rank

29.36%
MLEC market capitalization is higher than 29.36% of companies in Healthcare sector

Technical

Beta

0.13
MLEC beta is 0.13

200-day SMA

$0.91
MLEC price is currently -17.17% below its 200-day simple moving average

14-day RSI

50.87
MLEC 14-day relative strength index is 50.87

30-day Relative Volume

0.80
MLEC 30-day relative volume is 0.80

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$5.63 M
MLEC annual revenue is $5.63 million

Annual Revenue Analysts Estimate

$6.64 M
MLEC annual revenue is currently -15.30% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+521.56%
MLEC annual revenue is up +521.56% year-on-year

Annual Revenue Sector Rank

23.65%
MLEC annual revenue is higher than 23.65% of companies in Healthcare sector

Profit

Annual Gross Profit

$472.60 K
MLEC annual gross profit is $472.60 thousand

Annual Gross Margin

8.40%
MLEC annual gross profit margin is 8.40%

Annual Operating Profit

-$9.04 M
MLEC annual operating income is -$9.04 million

Annual Operating Margin

-160.76%
MLEC annual operating profit margin is -160.76%

Annual Net Income

-$7.31 M
MLEC annual net profit is -$7.31 million

Annual Net Margin

-129.99%
MLEC annual net profit margin is -129.99%

EPS

Annual EPS

-$0.19
MLEC annual earnings per share is -$0.19

Annual EPS Analysts Estimate

-
MLEC annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+87.33%
MLEC annual earnings per share is up +87.33% year-on-year

Annual EPS Sector Rank

78.1%
MLEC annual earnings per share is higher than 78.1% of companies in Healthcare sector

ROA & ROE

Annual ROA

-24.86%
MLEC annual return on assets is -24.86%

Annual ROE

-86.42%
MLEC annual return on equity is -86.42%

EBIT & EBITDA

Annual EBIT

-$7.19 M
MLEC annual earnings before interest & taxes is -$7.19 million

Annual EBITDA

-$7.19 M
MLEC annual EBITDA is -$7.19 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MLEC price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MLEC price to earnings ratio is unknown

PB Ratio

PB Ratio

5.09
MLEC price to book ratio is 5.09

PB Ratio Sector Rank

83.18%
MLEC price to book ratio is higher than 83.18% of companies in Healthcare sector

PS Ratio

PS Ratio

5.32
MLEC price to sales ratio is 5.32

PS Ratio Sector Rank

64.58%
MLEC price to sales ratio is higher than 64.58% of companies in Healthcare sector

Enterprise value

Enterprise Value

$47.45 M
MLEC enterprise value is $47.45 million

Enterprise Value Sector Rank

39.8%
MLEC enterprise value is higher than 39.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.29
MLEC EV/EBITDA is -8.29

EV/EBITDA Sector Rank

15.05%
MLEC EV/EBITDA is higher than 15.05% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.69
MLEC annual current ratio is 1.69

Annual Quick Ratio

0.92
MLEC annual quick ratio is 0.92

Leverage

Annual Debt To Equity

2.09
MLEC annual debt to equity ratio is 2.09

Annual Interest Coverage Ratio

-6.17
MLEC annual interest coverage ratio is -6.17

Risk & Stability

Piotroski F-Score

2
MLEC piotroski f-score is 2

Altman Z-Score

-2.36
MLEC altman z-score is -2.36

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$34.79 M
MLEC annual total assets is $34.79 million

Annual Non Current Assets

$21.04 M
MLEC annual long term assets is $21.04 million

Annual Current Assets

$13.75 M
MLEC annual total current assets is $13.75 million

Annual Cash & Cash Equivalents

$5.39 M
MLEC annual cash & cash equivalents is $5.39 million

Equity

Annual Book Value

$6.82 M
MLEC annual book value is $6.82 million

Annual Working Capital

$5.60 M
MLEC annual working capital is $5.60 million

Liabilities

Annual Total Liabilities

$27.97 M
MLEC annual total liabilities is $27.97 million

Annual Total Long Term Liabilities

$19.82 M
MLEC annual total long term liabilities is $19.82 million

Annual Current Liabilities

$8.15 M
MLEC annual total current liabilities is $8.15 million

Annual Accounts Payable

$873.50 K
MLEC annual accounts payable is $873.50 thousand

Debt

Annual Total Debt

$14.68 M
MLEC annual total debt is $14.68 million

Annual Total Debt 1-Year Change

+455.01%
MLEC annual total debt is up +455.01% year-on-year

Annual Long Term Debt

$11.95 M
MLEC annual long term debt is $11.95 million

Annual Short Term Debt

$2.73 M
MLEC annual short term debt is $2.73 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$14.67 M
MLEC annual total expenses is $14.67 million

Annual Operating Expenses

$9.52 M
MLEC annual total operating expenses is $9.52 million

Annual Cost Of Goods Sold

$5.15 M
MLEC annual cost of goods sold is $5.15 million

Annual SGA

$8.17 M
MLEC annual SGA is $8.17 million

Annual D&A

$1.01 M
MLEC annual depreciation & amortization is $1.01 million

Annual Interest Expense

$1.17 M
MLEC annual interest expense is $1.17 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$9.33 M
MLEC annual cash flow from operations is -$9.33 million

Annual CFO 1-Year Change

-24.19%
MLEC annual cash flow from operations is down -24.19% year-on-year

Annual CFI

$134.90 K
MLEC annual cash flow from investing activities is $134.90 thousand

Annual CFI 1-Year Change

+105.77%
MLEC annual cash flow from investing activities is up +105.77% year-on-year

Annual CFF

$11.71 M
MLEC annual cash flow from financing activities is $11.71 million

Annual CFF 1-Year Change

+3.81%
MLEC annual cash flow from financing activities is up +3.81% year-on-year

Free CashFlow

Annual FCF

-$9.33 M
MLEC annual free cash flow is -$9.33 million

Annual FCF 1-Year Change

-21.3%
MLEC annual free cash flow is down -21.3% year-on-year

CAPEX

Annual CAPEX

$158.30 K
MLEC annual capital expenditures is $158.30 thousand

Annual CAPEX 1-Year Change

-11.66%
MLEC annual capital expenditures is down -11.66% year-on-year

Institutional Ownership

Similar stocks

Pheton Holdings Ltd Class A (PTHL)
UBX logo
Unity Biotechnology (UBX)
NSYS logo
Nortech Systems Incorporated (NSYS)
POCI logo
Precision Optics (POCI)
DARE logo
Dare Bioscience (DARE)
LGVN logo
Longeveron (LGVN)
NRXP logo
NRx Pharmaceuticals (NRXP)
AXDX logo
Accelerate Diagnostics (AXDX)
PULM logo
Pulmatrix (PULM)

FAQ

  • What is the ticker symbol for Moolec Science SA?
  • Does Moolec Science SA pay dividends?
  • What sector is Moolec Science SA in?
  • What industry is Moolec Science SA in?
  • What country is Moolec Science SA based in?
  • When did Moolec Science SA go public?
  • Is Moolec Science SA in the S&P 500?
  • Is Moolec Science SA in the NASDAQ 100?
  • Is Moolec Science SA in the Dow Jones?
  • When was Moolec Science SA's last earnings report?
  • When does Moolec Science SA report earnings?
  • Should I buy Moolec Science SA stock now?

What is the ticker symbol for Moolec Science SA?

The ticker symbol for Moolec Science SA is NASDAQ:MLEC

Does Moolec Science SA pay dividends?

No, Moolec Science SA does not pay dividends

What sector is Moolec Science SA in?

Moolec Science SA is in the Healthcare sector

What industry is Moolec Science SA in?

Moolec Science SA is in the Biotechnology industry

What country is Moolec Science SA based in?

Moolec Science SA is headquartered in Luxembourg

When did Moolec Science SA go public?

Moolec Science SA's initial public offering (IPO) was on March 2, 2021

Is Moolec Science SA in the S&P 500?

No, Moolec Science SA is not included in the S&P 500 index

Is Moolec Science SA in the NASDAQ 100?

No, Moolec Science SA is not included in the NASDAQ 100 index

Is Moolec Science SA in the Dow Jones?

No, Moolec Science SA is not included in the Dow Jones index

When was Moolec Science SA's last earnings report?

Moolec Science SA's most recent earnings report was on Oct 2, 2024

When does Moolec Science SA report earnings?

The next expected earnings date for Moolec Science SA is Mar 3, 2025

Should I buy Moolec Science SA stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions